Caveolae-mediated effects of TNF-α on human skeletal muscle cells

Exp Cell Res. 2018 Sep 15;370(2):623-631. doi: 10.1016/j.yexcr.2018.07.027. Epub 2018 Jul 18.

Abstract

Chronic diseases are characterized by the production of pro-inflammatory cytokines such than TNF-α and are frequently correlated with muscle wasting conditions. Among the pleiotropic effects of TNF-α within the cell, its binding to TNFR1 receptor has been shown to activate sphingomyelinases leading to the production of ceramides. Sphingomyelinases and TNF receptor have been localized within caveolae which are specialized RAFT enriched in cholesterol and sphingolipids. Because of their inverted omega shape, maintained by the oligomerization of specialized proteins, caveolins and cavins, caveolae serve as membrane reservoir therefore providing mechanical protection to plasma membranes. Although sphingolipids metabolites, caveolins and TNF-α/TNFR1 have been shown to independently interfere with muscle physiology, no data have clearly demonstrated their concerted action on muscle cell regeneration. In this context, our study aimed at studying the molecular mechanisms induced by TNF-α at the level of caveolae in LHCN-M2 human muscle satellite cells. Here we showed that TNF-α-induced production of ROS and nSMase activation requires caveolin. More strikingly, we have demonstrated that TNF-α induces the formation of additional caveolae at the plasma membrane of myoblasts. Furthermore, TNF-α prevents myoblast fusion suggesting that inflammation could modulate caveolae organization/function and satellite cell function.

Keywords: Caveolae; Inflammation; Myoblasts; Oxidative stress; Sphingomyelinase; TNF-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caveolae / metabolism*
  • Caveolin 1 / metabolism
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cholesterol / metabolism
  • Humans
  • Muscle Fibers, Skeletal / metabolism*
  • Myoblasts / drug effects
  • Myoblasts / metabolism
  • RNA, Small Interfering / metabolism
  • Receptors, Tumor Necrosis Factor, Type I
  • Signal Transduction / drug effects
  • Tumor Necrosis Factor-alpha / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Caveolin 1
  • RNA, Small Interfering
  • Receptors, Tumor Necrosis Factor, Type I
  • TNFRSF1A protein, human
  • Tumor Necrosis Factor-alpha
  • Cholesterol